Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥223.70B | ¥177.98B | +25.7% |
| Operating Income | ¥27.84B | ¥10.98B | +153.5% |
| Ordinary Income | ¥29.19B | ¥13.83B | +111.0% |
| Net Income | ¥20.74B | ¥10.06B | +106.2% |
| ROE (Annualized) | 11.9% | 5.9% | - |
Executive Summary
This was a strong quarter, with significant increases in operating income and net income driven by higher revenue and the realization of operating leverage. Revenue was ¥223.70B (+25.7% YoY), operating income was ¥27.84B (+153.5%), ordinary income was ¥29.19B (+111.0%), and net income attributable to owners of the parent was ¥18.33B (+118.1%). The substantially faster growth in operating income than in revenue was primarily attributable to operating leverage resulting from an improved gross margin and restrained growth in SG&A expenses.
Factors Affecting Results
【Revenue】Revenue was ¥223.70B, up +25.7% YoY. By segment, the Green Energy & Chemicals Business Division grew substantially to ¥97.21B (+47.0%), while the core Functional Chemicals Business Division also remained solid at ¥122.70B (+12.8%). Functional Chemicals accounted for approximately 55% of the revenue mix, while Green Energy & Chemicals accounted for approximately 43%.
【Profit and Loss】Operating income was ¥27.84B (+153.5% YoY), and the operating margin improved by approximately 6.2pt from 6.2% in the same period of the previous year to 12.4%. While the gross margin rose to 25.2% (previous year: 22.1%), SG&A expenses increased by only +1.9%, resulting in a decline in the SG&A ratio to 12.8% (previous year: 15.9%). Profit growth exceeding revenue growth reflects structural improvement at the operating level. Ordinary income of ¥29.19B consisted of operating income plus ¥3.15B in non-operating income, including ¥1.04B in dividend income and ¥0.55B in foreign exchange gains, among other items; net financial income contributed positively. Extraordinary income totaled ¥0.87B, including a ¥0.58B gain on the sale of investment securities, while extraordinary losses totaled ¥1.24B, including ¥0.27B in impairment losses and other items, resulting in a net reduction of ¥0.38B. In the conversion to net income, income taxes and other taxes of ¥8.07B and net income attributable to non-controlling interests of ¥2.41B were deducted. Both revenue and profit increased, with the primary driver of profit growth being improved profitability in the core business.
Segment Analysis
The Functional Chemicals Business Division is the core business, with segment profit of ¥17.91B (+80.0% YoY), accounting for approximately 61% of total segment profit; its profit margin on external revenue was approximately 14.6%. The Green Energy & Chemicals Business Division recorded segment profit of ¥11.64B (+198.4%), the highest growth rate among the segments, with a profit margin of approximately 12.0%. Other Businesses generated segment profit of ¥0.39B, turning profitable from a loss of ¥0.25B in the same period of the previous year. Corporate adjustments were negative ¥0.76B, deteriorating from positive ¥0.23B in the same period of the previous year and partially offsetting the profit growth of the business divisions.
Key Financial Metrics
【Profitability】The operating margin improved by approximately 6.2pt from 6.2% in the same period of the previous year to 12.4%, supported by both the gross margin of 25.2% (previous year: 22.1%) and the SG&A ratio of 12.8% (previous year: 15.9%). Annualized ROE was 11.9%, reflecting improvements in the net profit margin and asset efficiency.【Cash Flow Quality】Non-operating income was limited to 1.4% of revenue, indicating that the core business was the primary driver of earnings growth. However, accounts receivable increased by +11.3% YoY and inventories by +12.2%, indicating an increase in working capital based on the difference between these growth rates and revenue growth.【Investment Efficiency】Investment securities of ¥263.41B accounted for 22.7% of total assets, a scale that could affect net assets and comprehensive income through valuation differences.【Financial Soundness】The equity ratio was 60.3%. Current assets of ¥483.64B compared with current liabilities of ¥252.98B indicate strong short-term payment capacity. Interest-bearing debt consisted primarily of long-term borrowings of ¥102.64B and bonds of ¥55.00B, indicating restrained financial leverage.
Cash Flow Analysis
Because actual figures from the statement of cash flows are not included in the disclosed information, cash trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥66.54B, slightly down from ¥68.97B in the same period of the previous year. Meanwhile, accounts receivable increased to ¥166.51B (+11.3% YoY) and inventories to ¥123.52B (+12.2%); although both increases were below the +25.7% growth in revenue, an accumulation of working capital was observed. Property, plant and equipment totaled ¥339.54B, up +1.6% YoY, suggesting that capital investment has continued at a moderate pace. Accounts payable increased to ¥103.48B (+12.5% YoY), with the increase in trade payables absorbing part of the increase in working capital. Overall, the pace of increase in accounts receivable and inventories is slightly ahead of profit growth, suggesting that the conversion of earnings into cash may require a certain amount of time.
Earnings Quality
Ordinary income was ¥29.19B versus operating income of ¥27.84B, meaning that non-operating items contributed net income of ¥1.34B. Non-operating income of ¥3.15B was limited to approximately 1.4% of revenue, with dividend income of ¥1.04B, foreign exchange gains of ¥0.55B, and interest income of ¥0.28B as the main components. Extraordinary income of ¥0.87B included a ¥0.58B gain on the sale of investment securities, while extraordinary losses of ¥1.24B included impairment losses of ¥0.27B and business restructuring expenses of ¥0.18B, resulting in a net reduction of ¥0.38B. Accordingly, the current period’s earnings growth can be evaluated as high quality, supported by a substantial increase in operating income rather than dependence on temporary gains from asset sales. Comprehensive income of ¥29.25B exceeded net income of ¥20.74B, primarily due to a ¥6.63B increase in the valuation difference on securities.
Earnings Forecasts and Guidance
The full-year company forecast is revenue of ¥860.0B (+16.5% YoY), operating income of ¥71.0B (+56.8%), and ordinary income of ¥79.0B (+52.1%). Q1 progress rates were 26.0% for revenue, 39.2% for operating income, 36.9% for ordinary income, and 33.3% for net income (attributable to owners of the parent), all exceeding the simple progress benchmark of 25%. Progress toward the operating income and ordinary income forecasts was particularly strong. The Q1 operating margin of 12.4% was significantly above the approximately 8.3% full-year forecast operating margin, suggesting that the recent strong performance has been incorporated to some extent into the latest revision of the earnings forecast. Going forward, market conditions, raw material costs, and product mix trends will determine whether the profit margin can be maintained throughout the year.
Shareholder Returns
The full-year dividend forecast is ¥110 per share (the previous year’s actual figure was disclosed as the combined interim and year-end dividend), and the full-year EPS forecast is ¥282.04, resulting in a calculated payout ratio of approximately 39.0%. No revision has been made to the dividend forecast. Net assets of ¥698.84B and an equity ratio of 60.3% provide a financial foundation supporting dividend continuity. However, accounts receivable and inventories are increasing at somewhat faster rates, and the cash support for dividend funding should be monitored together with future working capital trends.
Risk Factors
-
Volatility in chemical and energy markets and raw material and fuel prices: The Green Energy & Chemicals Business Division has expanded rapidly, with revenue up +47.0% and segment profit up +198.4%, creating the possibility of larger earnings fluctuations if market conditions reverse.
-
Increase in working capital: Accounts receivable increased by +11.3% YoY and inventories by +12.2%. Although both increased at rates below the +25.7% growth in revenue, trends in receivables collection and inventory levels will affect the conversion of earnings into cash.
-
Sustainability of Q1’s high profit margin: The 12.4% operating margin exceeds the approximately 8.3% implied by the full-year forecast. Whether the product mix and cost conditions can be maintained throughout the year will be key to achieving the earnings forecast.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 12.4% | 8.7% (4.2%–14.3%) | +3.8pt |
| Net Profit Margin | 9.3% | 7.1% (3.2%–10.6%) | +2.2pt |
Both the operating margin and net profit margin exceed the industry median, indicating that profitability is relatively high within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 25.7% | 6.2% (-1.1%–14.6%) | +19.5pt |
The revenue growth rate significantly exceeds the industry median, indicating a high-growth phase relative to the industry.
※Source: Compiled by the company
Key Takeaways from the Earnings Release
-
Operating income increased by +153.5% against revenue growth of +25.7%, confirming profit growth substantially exceeding revenue growth. Operating leverage resulting from improved gross margins and restrained SG&A growth was the primary driver of margin expansion, while dependence on temporary extraordinary income was limited.
-
Q1 progress rates against the full-year forecast were 39.2% for operating income and 36.9% for ordinary income, substantially exceeding the standard 25% progress benchmark and consistent with the details of the earnings forecast revision. The key focus going forward will be whether the recent high profitability can be maintained throughout the year.
-
Accounts receivable and inventories increased by +11.3% and +12.2% YoY, respectively. Although these increases were below revenue growth, an accumulation of working capital was observed. The speed at which profit growth converts into cash will be an important point for monitoring.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥3,428 |
| base | ¥3,502 |
| bull | ¥3,561 |
| Calculation Assumption | Value |
|---|---|
| Book Value Per Share (BPS) | ¥3,584 |
| Adjusted Forecast EPS | ¥303.2 |
| Cost of Equity r | 9.27% (10-year Japanese Government Bond 2.77% + Equity Risk Premium 6.00% + Size Premium 0.50%) |
| Persistence Coefficient of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 39.0% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the historical guidance achievement rate of peer companies in the same industry) |
| Implied PBR / PER | 0.98x / 11.5x |
Sensitivity: ¥3,405–¥3,603 at ±1% cost of equity, and ¥3,499–¥3,503 at ω±0.1.
Notes:
- Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
- Net assets as of the end of the quarter are used; there is a time lag relative to the full-year forecast.
- Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.
(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest Rate Reference Month: 2026-07 / This is a mechanically calculated value based solely on publicly disclosed data and is not a forecast of the market share price, a recommendation of any specific investment action, or a prediction or guarantee of future share prices.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility and, where necessary, after consulting with a professional.
---End of Report---